UK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:56
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0656 GMT [Dow Jones] AstraZeneca's (AZN.LN) Crestor patent victory has lifted a significant uncertainty says Shore Capital.
Read moreMARKET TALK: AstraZeneca Crestor Victory Removes Uncertainty
30th Jun 2010 07:56
0656 GMT [Dow Jones] AstraZeneca's (AZN.LN) Crestor patent victory has lifted a significant uncertainty says Shore Capital. Says while there may be little scope to upgrade consensus forecasts, thinks this removes a significant overhang from the AstraZeneca investment case. Thinks investors will now
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:52
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0652 GMT [Dow Jones] Jefferies International upgrades AstraZeneca (AZN.LN) to hold from underperform and boosts target price
Read moreMARKET TALK: Jefferies Upgrades AstraZeneca To Hold
30th Jun 2010 07:52
0652 GMT [Dow Jones] Jefferies International upgrades AstraZeneca (AZN.LN) to hold from underperform and boosts target price to 2850p from 2550p. This comes after AstraZeneca prevails in its U.S. legal challenge against numerous companies that sought to market generic versions of Crestor prior to it
Read moreLondon pre-open: Small gains ahead
30th Jun 2010 07:36
London's top stocks are expected to open only slightly higher following yesterday's heavy losses. Traders were nervy in Europe about bank payments that need to be made to the European Central Bank this week, while triple-digit falls on Wall Street added to London's woes on Tuesday. Today, traders e
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:12
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0612 GMT [Dow Jones] JPMorgan Cazenove upgrades AstraZeneca (AZN.LN) to neutral from underweight following the US Crestor pat
Read moreMARKET TALK: JPMorgan Upgrades AstraZeneca To Neutral
30th Jun 2010 07:12
0612 GMT [Dow Jones] JPMorgan Cazenove upgrades AstraZeneca (AZN.LN) to neutral from underweight following the US Crestor patent ruling in its favor. Raises its price target to 3360p from 2960p. Says while generic challengers are likely to appeal, the probability of reversing this ruling appears to
Read moreSUBSCRIBERS: AstraZeneca: Crestor Patent Upheld Already Reported
30th Jun 2010 07:08
Please disregard the headline timed 0601 GMT as this news was reported in full at 2108 GMT Tuesday. (END) Dow Jones Newswires June 30, 2010 02:08 ET (06:08 GMT)
Read moreMARKET TALK: UBS Ups AstraZeneca Target After Crestor Victory
30th Jun 2010 07:07
0607 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p after it successfully defends its U.S. Crestor patent. Says this victory significantly safeguards around 17% of earnings, at risk due to the Crestor trial. From here, expects earnings momentum to continue. Says wit
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:07
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0607 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p after it successfully defends its U.S.
Read moreAstra cheers Crestor patent victory
30th Jun 2010 07:07
Shares in AstraZeneca jumped nearly 10% after the Anglo-Swedish drugs giant received a favourable US ruling in its battle to keep control of the patents to its best-selling cholesterol-lowering drug Crestor. The ruling means that cheaper, generic versions of Astra's blockbuster drug can not enter t
Read moreWednesday's newspaper round-up: Budget cuts, BP, AstraZeneca
30th Jun 2010 06:42
George Osborne's austerity budget will result in the loss of up to 1.3m jobs across the economy over the next five years according to a private Treasury assessment of the planned spending cuts. Unpublished estimates of the impact of the biggest squeeze on public spending since the second world war
Read moreCORRECT: US Judge Upholds Patent For AstraZeneca's Crestor >AZN
29th Jun 2010 23:05
("US Judge Upholds Patent For AstraZeneca's Crestor" published at 5:08 p.m. EDT incorrectly implied in the third paragraph that global sales for Crestor in 2009 were $2.1 billion. That was the U.S. sales figure. A corrected version follows:) By Peter Loftus Of DOW JONES NEWSWIRES PHILADE
Read moreUPDATE: US Judge Upholds Patent For AstraZeneca's Crestor >AZN
29th Jun 2010 23:05
(Adds details about patent expiration in second paragaph; stock price in fourth paragraph; analyst reaction in fifth graph; additional details.) By Peter Loftus Of DOW JONES NEWSWIRES PHILADELPHIA (Dow Jones)--A U.S. judge has ruled that the patent for AstraZeneca PLC's (AZN, AZN.LN) blo
Read moreLondon close: Footsie dives on economic concerns
29th Jun 2010 16:31
London's leading shares ended with heavy losses as concerns about the global economy resurfaced again. Traders were nervy in Europe about bank payments that need to be made to the European Central Bank this week, while triple-digit falls on Wall Street added to London's woes. As in London, US in
Read more